Free Trial

Truist Financial's Rating of Disc Medicine on 10/19/2026

On October 19, 2026, Truist Financial updated its outlook on Disc Medicine (NASDAQ:IRON) with the action "Boost Price Target", setting a price target of $115.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Truist Financial Corporation

DateCompanyAction
11/2/2026
Crh Plc stock logo
CRH
CRH
Set Price Target
11/2/2026
CF Industries Holdings, Inc. stock logo
CF
CF Industries
Set Price Target
11/2/2026
Cimpress plc stock logo
CMPR
Cimpress
Lower Price Target
11/2/2026
Curbline Properties Corp. stock logo
CURB
Curbline Properties
Boost Price Target
11/2/2026
EQT Corporation stock logo
EQT
EQT
Boost Price Target
11/2/2026
FTI Consulting, Inc. stock logo
FCN
FTI Consulting
Reiterated Rating
More Ratings From Truist Financial Corporation